BioForce Nanosciences Holdings, Inc.
BFNH
$0.5279
$0.02444.85%
OTC PK
03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
---|---|---|---|---|---|
Revenue | -- | -- | -- | -- | -- |
Total Other Revenue | -- | -- | -- | -- | -- |
Total Revenue | -- | -- | -- | -- | -- |
Cost of Revenue | -- | -- | -- | -- | -- |
Gross Profit | -- | -- | -- | -- | -- |
SG&A Expenses | 4.32% | 3.92% | 1.99% | -1.66% | -2.15% |
Depreciation & Amortization | -- | -- | -- | -- | -- |
Other Operating Expenses | -- | -- | -- | -- | -- |
Total Operating Expenses | 4.32% | 3.92% | 1.99% | -1.66% | -2.15% |
Operating Income | -4.32% | -3.92% | -1.99% | 1.66% | 2.15% |
Income Before Tax | -173.81% | -3.92% | -1.99% | 1.66% | 2.15% |
Income Tax Expenses | -- | -- | -- | -- | -- |
Earnings from Continuing Operations | -173.81% | -3.92% | -1.99% | 1.66% | 2.15% |
Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
Minority Interest in Earnings | -- | -- | -- | -- | -- |
Net Income | -173.81% | -3.92% | -1.99% | 1.66% | 2.15% |
EBIT | -4.32% | -3.92% | -1.99% | 1.66% | 2.15% |
EBITDA | -- | -- | -- | -- | -- |
EPS Basic | -154.94% | -4.35% | -2.48% | 1.22% | 1.82% |
Normalized Basic EPS | -2.00% | -4.00% | -2.00% | 1.96% | 2.91% |
EPS Diluted | -154.94% | -4.35% | 25.68% | 28.00% | 28.32% |
Normalized Diluted EPS | -2.00% | -4.00% | -2.00% | 1.96% | 2.91% |
Average Basic Shares Outstanding | 2.54% | 0.00% | 0.00% | 0.00% | 0.00% |
Average Diluted Shares Outstanding | 2.54% | 0.00% | 0.00% | 0.00% | 0.00% |
Dividend Per Share | -- | -- | -- | -- | -- |
Payout Ratio | -- | -- | -- | -- | -- |